This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Chongqing Xingjie Shuxing Technology Partnership Enterprise (Limited Partnership), Xdcexplorer (Shanghai) Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Fei Peng: Innovator in Antibody Development
Introduction
Fei Peng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work is characterized by a focus on innovative solutions that address complex medical challenges.
Latest Patents
Fei Peng holds a patent for a "Humanized anti-TPBG antibody, preparation method therefor, conjugate thereof, and applications." This invention provides a humanized anti-TPBG antibody that includes a framework region comprising a residue of a human antibody framework region, along with one or more CDRs of a light-chain variable region or a heavy-chain variable region. This patent represents a significant advancement in antibody technology and its applications in medicine.
Career Highlights
Fei Peng is associated with Xdcexplorer (Shanghai) Co., Ltd., where he continues to push the boundaries of innovation in biotechnology. His work has garnered attention for its potential impact on therapeutic applications and disease treatment.
Collaborations
Fei Peng collaborates with talented professionals in his field, including Ying Zhang and Shiyong Gong. These collaborations enhance the research and development efforts at Xdcexplorer, fostering an environment of innovation and creativity.
Conclusion
Fei Peng's contributions to the field of biotechnology, particularly through his patent on humanized antibodies, highlight his role as a key innovator. His work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile